Trillium Therapeutics Inc.: management transactions · United States · SEC (Form 4) SEC:trillium-therapeutics-inc US US · SEC (Form 4)
Browse the full directors' dealings record of Trillium Therapeutics Inc., a listed equity based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). The latest transaction was filed on 19 November 2021 — Disposition. Among the most active insiders: Uger Robert. The full history is free.
Last declaration on 19 November 2021
Declarations 12 total
Executives ● Disposition3 SEC
75 shares
Common Shares
SEC:0001104659-21-141749 · 17 Nov 2021
Executives ● Disposition9 SEC
05,736,363 shares 0
Common Shares
SEC:0001209191-21-065762 · 17 Nov 2021
Executives ● Disposition2 SEC
75 shares
Common Shares
SEC:0001104659-21-141749:0 · 17 Nov 2021
Executives ● Disposition11 SEC
05,736,363 shares 0
Common Shares
SEC:0001209191-21-065762:0 · 17 Nov 2021
Executives ◇ Options12 SEC
€940 3,646 shares @ €0.2577 33.2% of flow
Common Shares
SEC:0001062993-21-006419 · 7 Jul 2021
Executives ◇ Options13 SEC
€940 3,646 shares @ €0.2577 16.6% of flow
Common Shares
SEC:0001062993-21-006419:0 · 7 Jul 2021
Executives ◇ Options12 SEC
€942 3,646 shares @ €0.2583 33.3% of flow
Common Shares
SEC:0001062993-21-005487 · 7 Jun 2021
Executives ◇ Options13 SEC
€942 3,646 shares @ €0.2583 16.7% of flow
Common Shares
SEC:0001062993-21-005487:0 · 7 Jun 2021
Executives ◇ Options22 SEC
€32,148 87,500 shares @ €0.3674 100.0% of flow
Common Shares
SEC:0001062993-21-004511 · 11 May 2021
Executives ◇ Options27 SEC
€32,148 87,500 shares @ €0.3674 50.0% of flow
Common Shares
SEC:0001062993-21-004511:0 · 11 May 2021
Executives ◇ Options12 SEC
€946 3,646 shares @ €0.2594 33.4% of flow
Common Shares
SEC:0001062993-21-004390 · 7 May 2021
Executives ◇ Options13 SEC
€946 3,646 shares @ €0.2594 16.7% of flow
Common Shares
SEC:0001062993-21-004390:0 · 7 May 2021